NASDAQ:AMEH - Apollo Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $83.50
  • Forecasted Upside: 17.06 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$71.33
▼ -0.59 (-0.82%)

This chart shows the closing price for AMEH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Apollo Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for AMEH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for AMEH

Analyst Price Target is $83.50
▲ +17.06% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Apollo Medical in the last 3 months. The average price target is $83.50, with a high forecast of $92.00 and a low forecast of $75.00. The average price target represents a 17.06% upside from the last price of $71.33.

This chart shows the closing price for AMEH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Apollo Medical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/29/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/24/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/24/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/23/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/21/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
8/12/2021BarclaysInitiated CoverageEqual Weight$92.00High
8/10/2021Colliers SecuritiesReiterated RatingBuyHigh
6/25/2021Colliers SecuritiesBoost Price TargetTop Pick ➝ Buy$36.00 ➝ $75.00High
4/26/2018Dougherty & CoReiterated RatingBuyMedium
4/26/2018Dougherty & CoInitiated CoverageBuy$25.00Medium
(Data available from 10/22/2016 forward)

News Sentiment Rating

0.44 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/26/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/25/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/25/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/24/2021
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/23/2021
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/22/2021
  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
10/22/2021

Current Sentiment

  • 2 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Apollo Medical logo
Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It focuses on providing population health management and healthcare delivery platform. The company operates as an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.
Read More

Today's Range

Now: $71.33
Low: $70.93
High: $72.42

50 Day Range

MA: $82.01
Low: $68.79
High: $100.41

52 Week Range

Now: $71.33
Low: $17.00
High: $114.55

Volume

4,722 shs

Average Volume

381,051 shs

Market Capitalization

$3.95 billion

P/E Ratio

54.87

Dividend Yield

N/A

Beta

0.55

Frequently Asked Questions

What sell-side analysts currently cover shares of Apollo Medical?

The following sell-side analysts have issued reports on Apollo Medical in the last year: Barclays PLC, Colliers Securities, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for AMEH.

What is the current price target for Apollo Medical?

2 Wall Street analysts have set twelve-month price targets for Apollo Medical in the last year. Their average twelve-month price target is $83.50, suggesting a possible upside of 16.1%. Barclays PLC has the highest price target set, predicting AMEH will reach $92.00 in the next twelve months. Colliers Securities has the lowest price target set, forecasting a price of $75.00 for Apollo Medical in the next year.
View the latest price targets for AMEH.

What is the current consensus analyst rating for Apollo Medical?

Apollo Medical currently has 1 hold rating and 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe AMEH will outperform the market and that investors should add to their positions of Apollo Medical.
View the latest ratings for AMEH.

How do I contact Apollo Medical's investor relations team?

Apollo Medical's physical mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company's listed phone number is (626) 943-6491 and its investor relations email address is [email protected] The official website for Apollo Medical is www.apollomed.net.